Yazar "Altun, G. Durmus" seçeneğine göre listele
Listeleniyor 1 - 19 / 19
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Assesment of Adrenal Metastasis in Patients with Lung Cancer using F-18 FDG PET/CT(Springer, 2012) Aksoy, S.; Serim, B. Dirlik; Ustun, F.; Altun, G. Durmus[Abstract Not Available]Öğe The contribution of protocol selection to diagnostic accuracy in MIBI parathyroid scintigraphy: reevaluation with SPECT/CT and histopathologic findings(Springer, 2020) Ozdemir, B.; Korkmaz, U.; Soyluoglu, S.; Gokdemir, E.; Altun, G. Durmus[Abstract Not Available]Öğe Cut-off level for Tc-99m sestamibi cavity/myocardium count ratio in patients with left ventricular hypertrophy(Oxford Univ Press, 2011) Torun, N.; Altun, G. Durmus; Altun, A.[Abstract Not Available]Öğe Do Histological Patterns of Primary Tumor Predict Metabolic Patterns detected by FDG PET/CT in Differentiated Thyroid Cancer Patients(Springer, 2020) Soyluoglu, S.; Tastekin, E.; Korkmaz, U.; Orum, S.; Altun, G. Durmus[Abstract Not Available]Öğe The evaluation of inter- and intraobserver variability of 99mTc-Dimercaptosuccinic acid SPECT renal scintigraphy(Springer, 2015) Can, U.; Altun, G. Durmus[Abstract Not Available]Öğe Evaluation of Iodine-131 Labelled Lawsone (2-Hydroxy-1,4-Naphthoquinone) Compound's Transdermal and Intravenous Biodistribution(Springer, 2020) Tekin, V.; Korkmaz, U.; Ince, I.; Kutlubay, I.; Altun, G. Durmus; Muftuler, F. Biber[Abstract Not Available]Öğe PET/CT in Patients with Cancer of Unknown PrimaryPreliminary Results: Characterization of FDG PET/CT Findings in Occult Lung Cancer and Relation of Results with Pathological Diagnosis and Survival(Springer, 2022) Aslan, A.; Korkmaz, U.; Soyluoglu, S.; Altun, G. Durmus[Abstract Not Available]Öğe Pre-therapy I-131 uptake value as a prediction method for metastatic lymph node status in patients with differentiated thyroid carcinoma(Springer, 2015) Aktas, G. Ege; Demir, S. Soyluoglu; Ustun, F.; Sarikaya, A.; Altun, G. Durmus[Abstract Not Available]Öğe Predictive value of dual time point imaging differentiation between malign and benign pancreatic lesions, Preliminary results(Springer, 2014) Ustun, F.; Ergulen, A.; Altun, G. Durmus[Abstract Not Available]Öğe PROTECTIVE ROLE OF CARNITINE AGAINST RADIATION-INDUCED KIDNEY DAMAGE IN INFANT RATS: SCINTIGRAPHIC AND HISTOPATHOLOGIC EVALUATION(Elsevier Ireland Ltd, 2011) Rusen, C.; Altun, G. Durmus; Puyan, F. Oz; Saynak, M.; Ibis, K.; Ozen, A.; Bayir-Angin, G.[Abstract Not Available]Öğe The relationship between Ga-68 PSMA accumulation intensity and Gleason score, PSA levels in primary staging and evaluation of biochemical recurrence of prostate cancer: The preliminary results(Springer, 2017) Aktas, G. Ege; Caloglu, V.; Can, N.; Akdere, H.; Ustun, F.; Altun, G. Durmus[Abstract Not Available]Öğe Relationship of F-18 FDG PET/CT Imaging Findings with Bone Trauma Age(Springer, 2021) Orun, S.; Korkmaz, U.; Soyluoglu, S.; Altun, G. Durmus[Abstract Not Available]Öğe The Role and Impact of 68Ga-PSMA PET/CT in Primary Staging of Prostate Cancer: Preliminary Results in Relation to AJCC Risk Group Staging(Springer, 2018) Aktas, L. Ege; Korkmaz, U.; Akdere, H.; Altun, G. Durmus[Abstract Not Available]Öğe The Role of Indices Obtained from Positron Emission Tomography for Predicting Prognosis in Patients with NonHodgkin's Lymphomas(Springer, 2013) Serim, B. Dirlik; Umit, E.; Ustun, F.; Aksoy, S.; Demir, M.; Altun, G. Durmus[Abstract Not Available]Öğe Staging and Indices measured with 18F-FDG PET/CT as a predictor of survival in Non-hodgkin's lymphoma(Springer, 2015) Serim, B. Dirlik; Umit, E.; Ustun, F.; Tokuc, B.; Demir, M.; Altun, G. Durmus[Abstract Not Available]Öğe Tumor characteristics of lung cancer in predicting axillary lymph node metastases(Elsevier Espana Slu, 2019) Ustun, F.; Tokuc, B.; Tastekin, E.; Altun, G. DurmusObjective: In lung cancer, axillary lymph node metastases (ALM) are rare, and according to the 8th grading system, it is classified as M1b disease. The aim of this study is to evaluate 1 ) the presence of ALM and2) the effect of the primary tumors characteristics on the development of ALM. Methods: We performed a descriptive cross-sectional study, with retrospective revision, to identify ALM. Results: There were 157 patients included in this analysis: ALM (63 patients) and control group (94 patients). The presence of extrathoracic lymph node, contralateral pulmonary parenchymal and distant metastasis and all SUVmax values were significantly higher in the study group versus the control group (P< 0.05). The SUVmax value of the primary tumor was not a predictor of ALM. According to the primary histopathologic diagnosis, small cell lung cancer was found to cause ALM development 3.4 times as much as squamous cancer (SQC) (OR: 3.40 [95% CI 1.3-10.20], P= 0.029) and adenocarcinoma group was found to cause ALM development 4 times as much as SQC (OR: 4.02 [95% CI 1.73-9.34], P= 0.001). The likelihood of developing ALM was significantly higher in tumors located in the central and upper lobe versus the lower lobe. Conclusion: The finding of ALM on PET/CT images, the necessity of histopathologic confirmation is determined according to the results of primary tumor localization, primary tumor histopathology, M stage on PET/CT imaging, localization of ALM according to primary tumor, and N stage on PET/CT imaging. (C) 2018 Sociedad Espanola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espana, S.L.U. All rights reserved.Öğe The Value of Myocardial Perfusion Scintigraphy Findings on Early-Onset Cardiac Event Risk in Patients with Coronary Artery Bypass Graft and Percutaneous Coronary Intervention: Single Center Preliminary Results(Springer, 2018) Serim, B. Dirlik; Altun, G. Durmus[Abstract Not Available]Öğe Value of Tc-99m MIBI myocardial perfusion scintigraphy in predicting non-critical coronary stenosis(Springer, 2016) Serim, B. Dirlik; Yilmaztepe, M.; Yigit, E.; Yigit, Z.; Altun, G. Durmus[Abstract Not Available]Öğe Which factors are affecting development of the axillary metastasis in lung cancer?(Springer, 2015) Ustun, F.; Altun, G. Durmus[Abstract Not Available]
